ATE296352T1 - Werkstoffe und verfahren zur modulierung der p66 expression - Google Patents

Werkstoffe und verfahren zur modulierung der p66 expression

Info

Publication number
ATE296352T1
ATE296352T1 AT00911131T AT00911131T ATE296352T1 AT E296352 T1 ATE296352 T1 AT E296352T1 AT 00911131 T AT00911131 T AT 00911131T AT 00911131 T AT00911131 T AT 00911131T AT E296352 T1 ATE296352 T1 AT E296352T1
Authority
AT
Austria
Prior art keywords
shc
serine
expression
vitro
vivo
Prior art date
Application number
AT00911131T
Other languages
English (en)
Inventor
Pier Giuseppe Pelicci
Marco Giorgio
Enrica Migliaccio
Luisa Lanfrancone
Original Assignee
Congenia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Congenia S R L filed Critical Congenia S R L
Application granted granted Critical
Publication of ATE296352T1 publication Critical patent/ATE296352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00911131T 1999-03-22 2000-03-22 Werkstoffe und verfahren zur modulierung der p66 expression ATE296352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906515.3A GB9906515D0 (en) 1999-03-22 1999-03-22 Materials and methods relating to the effects oF P66 expression
PCT/GB2000/001079 WO2000056886A1 (en) 1999-03-22 2000-03-22 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION

Publications (1)

Publication Number Publication Date
ATE296352T1 true ATE296352T1 (de) 2005-06-15

Family

ID=10850083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911131T ATE296352T1 (de) 1999-03-22 2000-03-22 Werkstoffe und verfahren zur modulierung der p66 expression

Country Status (10)

Country Link
EP (1) EP1163335B1 (de)
JP (1) JP2002539789A (de)
AT (1) ATE296352T1 (de)
AU (1) AU778301B2 (de)
CA (1) CA2367464A1 (de)
DE (1) DE60020348T2 (de)
DK (1) DK1163335T3 (de)
ES (1) ES2243237T3 (de)
GB (1) GB9906515D0 (de)
WO (1) WO2000056886A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4694786B2 (ja) * 2002-03-01 2011-06-08 ロジャー・ウィリアムズ・ホスピタル 乳房、前立腺および卵巣の癌の予測のための、Ｓｈｃタンパク質に関連する方法および組成物
GB0722759D0 (en) * 2007-11-20 2008-01-02 Congenia S R L Antisense oligonucleotides for the modulation of gene expression and methods relating to the use thereof
US20140179774A1 (en) * 2012-12-26 2014-06-26 Industrial Technology Research Institute Methods for inhibition of shc-1/p66 to combat aging-related diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744313A (en) * 1994-12-09 1998-04-28 The Regents Of The University Of California Assay employing novel protein domain which binds tyrosine phosphorylated proteins

Also Published As

Publication number Publication date
DE60020348T2 (de) 2006-02-02
DE60020348D1 (de) 2005-06-30
AU3312400A (en) 2000-10-09
GB9906515D0 (en) 1999-05-19
WO2000056886A1 (en) 2000-09-28
AU778301B2 (en) 2004-11-25
DK1163335T3 (da) 2005-09-19
CA2367464A1 (en) 2000-09-28
EP1163335A1 (de) 2001-12-19
EP1163335B1 (de) 2005-05-25
JP2002539789A (ja) 2002-11-26
ES2243237T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
ATE229007T1 (de) 6-benzyl-2h-pyridazin-3-on derivate,deren herstellung und deren verwendung als inhibitoren der prostaglandin g/h synthase i and ii (cox i and cox ii)
SV1999000102A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa. ref. pcs 9475 afae/bb.
EP2000136A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Entzündungskrankheiten mittels Topoisomerase-Inhibitoren
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ATE421954T1 (de) Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
EP1580268A4 (de) D-aminotransferasemutante und verfahren zur herstellung eines optisch aktiven glutaminsäurederivats unter verwendung davon
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
HK1091112A1 (en) Compounds and methods for increasing neurogenesis
ATE250571T1 (de) Kaliumkanal-blocker
TR200103493T2 (tr) Metaloproteaz önleyicileri
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
ES2191076T3 (es) Nuevos derivados de 1-aril-pirazol y su empleo como plaguicidas.
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
ATE406382T1 (de) Tropoelastinderivate
DE69708121D1 (de) Halogenid-enthaltende insulinzubereitungen
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
ITMI20020960A1 (it) Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
ATE296352T1 (de) Werkstoffe und verfahren zur modulierung der p66 expression
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
YU12397A (en) NOVEL PYRIMIDO [1,2-a] INDOLES
PT983272E (pt) Nova classe de compostos fotoactivos derivados de benzoporfirina
ATE408009T1 (de) Identifizierung und charakterisierung einer anthocyaninmutante (ant1) in tomate
AU2003276427A1 (en) Genetic markers on chromosome 12 associated to bipolar or unipolar disorders

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1163335

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee